{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:05:43Z","timestamp":1784307943461,"version":"3.55.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bulcan.2026.03.017","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T20:02:09Z","timestamp":1780603329000},"page":"873-887","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u00c9tat des lieux et innovations dans les strat\u00e9gies de pr\u00e9vention et d\u00e9pistage du cancer du sein"],"prefix":"10.1016","volume":"113","author":[{"given":"Lucie","family":"V\u00e9ron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Balleyguier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Lefeuvre-Plesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Fervers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natacha","family":"Joyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Caron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzette","family":"Delaloge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bulcan.2026.03.017_bib0485","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36\u00a0cancers in 185\u00a0countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.bulcan.2026.03.017_bib0490","doi-asserted-by":"crossref","first-page":"104555","DOI":"10.1016\/j.breast.2025.104555","article-title":"Increasing incidence of breast cancer in young women over time","volume":"83","author":"Pujol","year":"2025","journal-title":"Breast"},{"issue":"19","key":"10.1016\/j.bulcan.2026.03.017_bib0495","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1001\/jama.2025.16372","article-title":"Pathogenic germline variants in cancer susceptibility genes","volume":"334","author":"Idumah","year":"2025","journal-title":"JAMA"},{"issue":"1175","key":"10.1016\/j.bulcan.2026.03.017_bib0500","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1093\/bjr\/tqaf131","article-title":"Long-term breast cancer risk post childhood cancer radiotherapy: data-driven screening recommendations for survivors","volume":"98","author":"Demoor-Goldschmidt","year":"2025","journal-title":"Br J Radiol"},{"key":"10.1016\/j.bulcan.2026.03.017_bib0505","doi-asserted-by":"crossref","first-page":"108943","DOI":"10.1016\/j.envint.2024.108943","article-title":"Multi-pollutant exposure profiles associated with breast cancer risk: a Bayesian profile regression analysis in the French E3N cohort","volume":"190","author":"Giampiccolo","year":"2024","journal-title":"Environ Int"},{"issue":"5","key":"10.1016\/j.bulcan.2026.03.017_bib0510","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/em.22155","article-title":"Prenatal diethylstilbestrol exposure and cancer risk in women","volume":"60","author":"Troisi","year":"2019","journal-title":"Environ Mol Mutagen"},{"key":"10.1016\/j.bulcan.2026.03.017_bib0515","series-title":"Cancer du sein [Internet]","year":"2025"},{"issue":"3","key":"10.1016\/j.bulcan.2026.03.017_bib0520","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/ijc.35173","article-title":"Impact of organized and opportunistic screening on excess mortality and on social inequalities in breast cancer survival","volume":"156","author":"Poiseuil","year":"2025","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bulcan.2026.03.017_bib0525","series-title":"Pr\u00e9sentation du rapport annuel \u00ab\u00a0Charges et produits pour 2026\u00a0\u00bb [Internet]","year":"2025"},{"issue":"8043","key":"10.1016\/j.bulcan.2026.03.017_bib0530","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41586-024-08129-x","article-title":"Normal breast tissues harbour rare populations of aneuploid epithelial cells","volume":"636","author":"Lin","year":"2024","journal-title":"Nature"},{"issue":"7974","key":"10.1016\/j.bulcan.2026.03.017_bib0535","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41586-023-06333-9","article-title":"Evolutionary histories of breast cancer and related clones","volume":"620","author":"Nishimura","year":"2023","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.bulcan.2026.03.017_bib0540","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.cell.2023.03.013","article-title":"Impact of risk factors on early cancer evolution","volume":"186","author":"Weeden","year":"2023","journal-title":"Cell"},{"issue":"7955","key":"10.1016\/j.bulcan.2026.03.017_bib0545","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41586-023-05874-3","article-title":"Lung adenocarcinoma promotion by air pollutants","volume":"616","author":"Hill","year":"2023","journal-title":"Nature"},{"issue":"7972","key":"10.1016\/j.bulcan.2026.03.017_bib0550","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41586-023-06252-9","article-title":"A spatially resolved single-cell genomic atlas of the adult human breast","volume":"620","author":"Kumar","year":"2023","journal-title":"Nature"},{"issue":"8028","key":"10.1016\/j.bulcan.2026.03.017_bib0555","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41586-024-07882-3","article-title":"Mechanisms that clear mutations drive field cancerization in mammary tissue","volume":"633","author":"Ciwinska","year":"2024","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.bulcan.2026.03.017_bib0560","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1158\/1940-6207.CAPR-25-0035","article-title":"Precision prevention studies: a targeted approach to cancer prevention","volume":"18","author":"Blagden","year":"2025","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.bulcan.2026.03.017_bib0565","unstructured":"D\u00e9pistage organis\u00e9 du cancer du sein pour les femmes entre 50\u00a0et 74\u00a0ans [Internet]. [cit\u00e9 19\u00a0nov 2025]. Disponible sur\u00a0: https:\/\/www.ameli.fr\/hauts-de-seine\/assure\/sante\/themes\/cancer-sein\/depistage-organise-50-74-ans."},{"key":"10.1016\/j.bulcan.2026.03.017_bib0570","unstructured":"Rogel A.\u00a0Couverture totale du d\u00e9pistage du cancer du sein, dans et hors programme organis\u00e9, de 2016\u00a0\u00e0 2022\u00a0en France hexagonale\/Breast cancer screening coverage within and outside the organised programme, 2016\u20132022, mainland France."},{"key":"10.1016\/j.bulcan.2026.03.017_bib0575","unstructured":"Panorama des cancers en France 2025, \u00e9dition sp\u00e9ciale 20\u00a0ans [Internet]. [cit\u00e9 19\u00a0nov 2025]. Disponible sur\u00a0: https:\/\/www.cancer.fr\/catalogue-des-publications\/panorama-des-cancers-en-france-2025-edition-speciale-20-ans."},{"issue":"21","key":"10.1016\/j.bulcan.2026.03.017_bib0580","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMoa2409932","article-title":"Overall survival with pembrolizumab in early-stage triple-negative breast cancer","volume":"391","author":"Schmid","year":"2024","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.bulcan.2026.03.017_bib0585","doi-asserted-by":"crossref","first-page":"105858","DOI":"10.1016\/j.esmoop.2025.105858","article-title":"Adjuvant ribociclib plus nonsteroidal aromatase inhibitor therapy in patients with HR-positive\/HER2-negative early breast cancer: 5-year follow-up of NATALEE efficacy outcomes and updated overall survival","volume":"10","author":"Crown","year":"2025","journal-title":"ESMO Open"},{"issue":"2","key":"10.1016\/j.bulcan.2026.03.017_bib0590","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.annonc.2025.10.005","article-title":"Overall survival with abemaciclib in early breast cancer","volume":"37","author":"Johnston","year":"2025","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.bulcan.2026.03.017_bib0595","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMoa2406070","article-title":"Survival with trastuzumab emtansine in residual HER2-positive breast cancer","volume":"392","author":"Geyer","year":"2025","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.bulcan.2026.03.017_bib0600","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.annonc.2022.09.159","article-title":"Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1\/2\u00a0and high-risk, early breast cancer","volume":"33","author":"Geyer","year":"2022","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.bulcan.2026.03.017_bib0605","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1056\/NEJMoa1612645","article-title":"Adjuvant capecitabine for breast cancer after preoperative chemotherapy","volume":"376","author":"Masuda","year":"2017","journal-title":"N Engl J Med"},{"issue":"10503","key":"10.1016\/j.bulcan.2026.03.017_bib0610","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0140-6736(25)01013-X","article-title":"Extending the duration of endocrine treatment for early breast cancer: patient-level meta-analysis of 12\u00a0randomised trials of aromatase inhibitors in 22,031\u00a0postmenopausal women already treated with at least 5\u00a0years of endocrine therapy","volume":"406","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.bulcan.2026.03.017_bib0615","unstructured":"Mettre en \u0153uvre en contexte fran\u00e7ais des politiques publiques int\u00e9gr\u00e9es favorables \u00e0 la qualit\u00e9 de vie. Pistes pour une pr\u00e9vention primordiale des fardeaux de sant\u00e9 [Internet]. [cit\u00e9 24\u00a0oct 2025]. Disponible sur\u00a0: https:\/\/www.hcsp.fr\/explore.cgi\/avisrapportsdomaine?clefr=1454."},{"issue":"4","key":"10.1016\/j.bulcan.2026.03.017_bib0620","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1158\/1940-6207.CAPR-23-0386","article-title":"An integrated cancer prevention strategy: the viewpoint of the Leon-Berard Comprehensive Cancer Center Lyon, France","volume":"17","author":"Fervers","year":"2024","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.bulcan.2026.03.017_bib0625","unstructured":"Cancer IND. Strat\u00e9gie d\u00e9cennale de lutte contre les cancers 2021\u20132030 [Internet]. [cit\u00e9 24\u00a0oct 2025]. Disponible sur\u00a0: https:\/\/www.cancer.fr\/l-institut-national-du-cancer\/la-strategie-de-lutte-contre-les-cancers-en-france\/strategie-decennale-de-lutte-contre-les-cancers-2021-2030."},{"key":"10.1016\/j.bulcan.2026.03.017_bib0630","unstructured":"IARC. Methods for evaluating tobacco control policies [Internet]. [cit\u00e9 24\u00a0oct 2025]. Disponible sur\u00a0: http:\/\/publications.iarc.who.int\/Book-And-Report-Series\/Iarc-Handbooks-Of-Cancer-Prevention\/Methods-For-Evaluating-Tobacco-Control-Policies-2008."},{"issue":"4","key":"10.1016\/j.bulcan.2026.03.017_bib0635","doi-asserted-by":"crossref","first-page":"e261","DOI":"10.1016\/S2468-2667(24)00018-5","article-title":"Life course epidemiology and public health","volume":"9","author":"Wagner","year":"2024","journal-title":"Lancet Public Health"},{"issue":"1","key":"10.1016\/j.bulcan.2026.03.017_bib0640","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1186\/s12885-022-09484-6","article-title":"Study protocol comparing the ethical, psychological and socio-economic impact of personalised breast cancer screening to that of standard screening in the \u201cMy Personal Breast Screening\u201d (MyPeBS) randomised clinical trial","volume":"22","author":"Roux","year":"2022","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.bulcan.2026.03.017_bib0645","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s10549-021-06346-w","article-title":"The WISDOM study: a new approach to screening can and should be tested","volume":"189","author":"Esserman","year":"2021","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"10.1016\/j.bulcan.2026.03.017_bib0650","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/jama.2025.24784","article-title":"Risk-based vs. annual breast cancer screening: the WISDOM randomized clinical trial","volume":"335","author":"Esserman","year":"2025","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.bulcan.2026.03.017_bib0655","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1007\/s00330-022-08617-6","article-title":"Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI)","volume":"32","author":"Mann","year":"2022","journal-title":"Eur Radiol"},{"issue":"22","key":"10.1016\/j.bulcan.2026.03.017_bib0660","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1903986","article-title":"Supplemental MRI screening for women with extremely dense breast tissue","volume":"381","author":"Bakker","year":"2019","journal-title":"N Engl J Med"},{"issue":"10493","key":"10.1016\/j.bulcan.2026.03.017_bib0665","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/S0140-6736(25)00582-3","article-title":"Comparison of supplemental breast cancer imaging techniques\u00a0\u2014\u00a0interim results from the BRAID randomised controlled trial","volume":"405","author":"Gilbert","year":"2025","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bulcan.2026.03.017_bib0670","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13053-016-0048-3","article-title":"Intensive breast screening in BRCA2\u00a0mutation carriers is associated with reduced breast cancer specific and all cause mortality","volume":"14","author":"Evans","year":"2016","journal-title":"Hered Cancer Clin Pract"},{"issue":"4","key":"10.1016\/j.bulcan.2026.03.017_bib0675","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/jamaoncol.2023.6944","article-title":"MRI surveillance and breast cancer mortality in women with BRCA1\u00a0and BRCA2\u00a0sequence variations","volume":"10","author":"Lubinski","year":"2024","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.bulcan.2026.03.017_bib0680","unstructured":"European guidelines on breast cancer screening and diagnosis\u00a0|\u00a0European Commission Initiative on Breast and Colorectal cancer [Internet]. [cit\u00e9 7\u00a0d\u00e9c 2025]. Disponible sur\u00a0: https:\/\/cancer-screening-and-care.jrc.ec.europa.eu\/en\/ecibc\/european-breast-cancer-guidelines?topic=65&usertype=60&updatef2=0."},{"issue":"16","key":"10.1016\/j.bulcan.2026.03.017_bib0685","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1200\/JCO.2015.63.4147","article-title":"Adjunct screening with tomosynthesis or ultrasound in women with mammography-negative dense breasts: interim report of a prospective comparative trial","volume":"34","author":"Tagliafico","year":"2016","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.bulcan.2026.03.017_bib0690","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S1470-2045(23)00298-X","volume":"24","author":"L\u00e5ng","year":"2023","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.bulcan.2026.03.017_bib0695","doi-asserted-by":"crossref","first-page":"e703","DOI":"10.1016\/S2589-7500(23)00153-X","article-title":"Artificial intelligence for breast cancer detection in screening mammography in Sweden: a prospective, population-based, paired-reader, non-inferiority study","volume":"5","author":"Dembrower","year":"2023","journal-title":"Lancet Digit Health"},{"issue":"5","key":"10.1016\/j.bulcan.2026.03.017_bib0700","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41568-025-00795-x","article-title":"Genomic and fragmentomic landscapes of cell-free DNA for early cancer detection","volume":"25","author":"Bruhm","year":"2025","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.bulcan.2026.03.017_bib0705","first-page":"368","article-title":"Cancer screening with multicancer detection tests: a translational science review","volume":"74","author":"Rubinstein","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"10.1016\/j.bulcan.2026.03.017_bib0710","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41571-025-01033-x","article-title":"Promises and pitfalls of multi-cancer early detection using liquid biopsy tests","volume":"22","author":"Wan","year":"2025","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.bulcan.2026.03.017_bib0715","article-title":"The National Health Service-Galleri multi-cancer screening trial: explanation and justification of unique and important design issues","author":"Sasieni","year":"2025","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.bulcan.2026.03.017_bib0720","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1038\/s41467-023-37626-2","article-title":"A precision environmental health approach to prevention of human disease","volume":"14","author":"Baccarelli","year":"2023","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.bulcan.2026.03.017_bib0725","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1158\/2159-8290.CD-17-1415","article-title":"Precision prevention and early detection of cancer: fundamental principles","volume":"8","author":"Rebbeck","year":"2018","journal-title":"Cancer Discov"},{"issue":"12","key":"10.1016\/j.bulcan.2026.03.017_bib0730","doi-asserted-by":"crossref","first-page":"e694","DOI":"10.1016\/S1470-2045(25)00463-2","article-title":"The Lucerne Toolbox 3: digital health and artificial intelligence to optimise the patient journey in early breast cancer-a multidisciplinary consensus","volume":"26","author":"Pfob","year":"2025","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.bulcan.2026.03.017_bib0735","first-page":"11","article-title":"Personalized early detection and prevention of breast cancer: ENVISION consensus statement","volume":"17","author":"Pashayan","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2026.03.017_bib0740","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1158\/1055-9965.EPI-25-0609","article-title":"Opportunities to avoid invasive cancer by diagnosis and interception of preneoplastic lesions and cancer risk conditions","volume":"35","author":"Pradhan","year":"2025","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.bulcan.2026.03.017_bib0745","doi-asserted-by":"crossref","first-page":"107075","DOI":"10.1016\/j.ypmed.2022.107075","article-title":"Towards implementation of comprehensive breast cancer risk prediction tools in health care for personalised prevention","volume":"159","author":"Moorthie","year":"2022","journal-title":"Prev Med"},{"key":"10.1016\/j.bulcan.2026.03.017_bib0750","series-title":"D\u00e9pistage du cancer du sein en France\u00a0: identification des femmes \u00e0 haut risque et modalit\u00e9s de d\u00e9pistage [Internet]","year":"2018"},{"key":"10.1016\/j.bulcan.2026.03.017_bib0755","unstructured":"Synth\u00e8se\u00a0\u2013\u00a0femmes porteuses d\u2019une mutation de BRCA1\u00a0ou BRCA2\/d\u00e9tection pr\u00e9coce du cancer du sein et des annexes et strat\u00e9gies de r\u00e9duction du risque [Internet]. [cit\u00e9 24\u00a0oct 2025]. Disponible sur\u00a0: https:\/\/www.cancer.fr\/catalogue-des-publications\/synthese-femmes-porteuses-d-une-mutation-de-brca1-ou-brca2-detection-precoce-du-cancer-du-sein-et-des-annexes-et-strategies-de-reduction-du-risque."},{"issue":"11","key":"10.1016\/j.bulcan.2026.03.017_bib0760","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41436-020-0884-4","article-title":"Validation of the BOADICEA model and a 313-variant polygenic risk score for breast cancer risk prediction in a Dutch prospective cohort","volume":"22","author":"Lakeman","year":"2020","journal-title":"Genet Med"},{"issue":"4","key":"10.1016\/j.bulcan.2026.03.017_bib0765","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/jmg-2022-108502","article-title":"Clinical applicability of the Polygenic Risk Score for breast cancer risk prediction in familial cases","volume":"60","author":"Lakeman","year":"2023","journal-title":"J Med Genet"},{"issue":"10","key":"10.1016\/j.bulcan.2026.03.017_bib0770","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/jnci\/djac142","article-title":"Deep learning vs. traditional breast cancer risk models to support risk-based mammography screening","volume":"114","author":"Lehman","year":"2022","journal-title":"J Natl Cancer Inst"},{"issue":"578","key":"10.1016\/j.bulcan.2026.03.017_bib0775","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba4373","article-title":"Toward robust mammography-based models for breast cancer risk","volume":"13","author":"Yala","year":"2021","journal-title":"Sci Transl Med"},{"issue":"16","key":"10.1016\/j.bulcan.2026.03.017_bib0780","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1200\/JCO.21.01337","article-title":"Multi-institutional validation of a mammography-based breast cancer risk model","volume":"40","author":"Yala","year":"2022","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2026.03.017_bib0785","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajhg.2018.11.002","article-title":"Polygenic risk scores for prediction of breast cancer and breast cancer subtypes","volume":"104","author":"Mavaddat","year":"2019","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.bulcan.2026.03.017_bib0790","doi-asserted-by":"crossref","first-page":"116096","DOI":"10.1016\/j.ejca.2025.116096","article-title":"Evaluating breast cancer screening consortium and MammoRisk plus polygenic risk score 313\u00a0for breast cancer risk prediction in UK Biobank","volume":"231","author":"Rassy","year":"2025","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bulcan.2026.03.017_bib0795","unstructured":"Masson E.\u00a0EM-Consulte [Internet]. [cit\u00e9 7\u00a0avr 2024]. MyPeBS International randomized study comparing personalised, risk-stratified to standard breast cancer screening in women aged 40\u201370: focus on recruitment strategy in France. Disponible sur\u00a0: https:\/\/www.em-consulte.com\/article\/1502763\/mypebs-international-randomized-study-comparing-pe."},{"key":"10.1016\/j.bulcan.2026.03.017_bib0800","unstructured":"PERSPECTIVE [Internet]. [cit\u00e9 6\u00a0nov 2025]. Accueil. Disponible sur\u00a0: https:\/\/etudeperspective.ca\/."},{"issue":"1","key":"10.1016\/j.bulcan.2026.03.017_bib0805","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/bjc.2012.204","article-title":"Long-term results of screening with magnetic resonance imaging in women with BRCA mutations","volume":"107","author":"Passaperuma","year":"2012","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.bulcan.2026.03.017_bib0810","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1148\/radiol.2442060461","article-title":"Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study","volume":"244","author":"Lehman","year":"2007","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.bulcan.2026.03.017_bib0815","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s11547-024-01797-9","article-title":"The risk-based breast screening (RIBBS) study protocol: a personalized screening model for young women","volume":"129","author":"Gennaro","year":"2024","journal-title":"Radiol Med"},{"key":"10.1016\/j.bulcan.2026.03.017_bib0820","unstructured":"NCCN [Internet]. [cit\u00e9 7\u00a0nov 2025]. Guidelines Detail. Disponible sur\u00a0: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=2&id=1420."},{"key":"10.1016\/j.bulcan.2026.03.017_bib0825","unstructured":"https:\/\/cdn.curie.fr\/media\/ckeditor_pdf\/Referentiels%20FAR%202024.pdf [Internet]. [cit\u00e9 7\u00a0nov 2025]. Disponible sur\u00a0: https:\/\/cdn.curie.fr\/media\/ckeditor_pdf\/Referentiels%20FAR%202024.pdf."},{"issue":"1","key":"10.1016\/j.bulcan.2026.03.017_bib0830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJMsr1407164","article-title":"Atypical hyperplasia of the breast\u00a0\u2014\u00a0risk assessment and management options","volume":"372","author":"Hartmann","year":"2015","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.bulcan.2026.03.017_bib0835","doi-asserted-by":"crossref","first-page":"11","DOI":"10.6004\/jnccn.2018.7099","article-title":"Diagnosis and management of high-risk breast lesions","volume":"16","author":"Thomas","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"issue":"9","key":"10.1016\/j.bulcan.2026.03.017_bib0840","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/jnci\/djac125","article-title":"Radiotherapy-related dose and irradiated volume effects on breast cancer risk among Hodgkin lymphoma survivors","volume":"114","author":"Roberti","year":"2022","journal-title":"J Natl Cancer Inst"},{"issue":"27","key":"10.1016\/j.bulcan.2026.03.017_bib0845","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1200\/JCO.20.02244","article-title":"Development and validation of a breast cancer risk prediction model for childhood cancer survivors treated with chest radiation: a report from the childhood cancer survivor study and the Dutch Hodgkin late effects and later cohorts","volume":"39","author":"Moskowitz","year":"2021","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.bulcan.2026.03.017_bib0850","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/jnci\/djae274","article-title":"Prediction of breast cancer risk for adolescents and young adults with Hodgkin lymphoma","volume":"117","author":"Roberti","year":"2024","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bulcan.2026.03.017_bib0855","unstructured":"Breast cancer probability calculator [Internet]. [cit\u00e9 7\u00a0nov 2025]. Disponible sur\u00a0: https:\/\/ccss.stjude.org\/resources\/calculators\/breast-cancer-probability-calculator.html."},{"key":"10.1016\/j.bulcan.2026.03.017_bib0860","series-title":"Orienter vos patientes [Internet]","year":"2024"},{"issue":"1","key":"10.1016\/j.bulcan.2026.03.017_bib0865","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/jnci\/djae208","article-title":"Genetic risk, health-associated lifestyle, and risk of early-onset total cancer and breast cancer","volume":"117","author":"Zhang","year":"2025","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"10.1016\/j.bulcan.2026.03.017_bib0870","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41416-020-0806-x","article-title":"Adherence to the WCRF\/AICR 2018\u00a0recommendations for cancer prevention and risk of cancer: prospective cohort studies of men and women","volume":"122","author":"Kaluza","year":"2020","journal-title":"Br J Cancer"},{"issue":"13","key":"10.1016\/j.bulcan.2026.03.017_bib0875","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1200\/JCO.19.00435","article-title":"Dietary modification and breast cancer mortality: long-term follow-up of the women's health initiative randomized trial","volume":"38","author":"Chlebowski","year":"2020","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.bulcan.2026.03.017_bib0880","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1200\/OP.21.00343","article-title":"Breast cancer prevention: time for change","volume":"17","author":"Chlebowski","year":"2021","journal-title":"JCO Oncol Pract"},{"issue":"4","key":"10.1016\/j.bulcan.2026.03.017_bib0885","article-title":"Risk-reducing medications for primary breast cancer: a network meta-analysis","volume":"4","author":"Mocellin","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bulcan.2026.03.017_bib0890","doi-asserted-by":"crossref","first-page":"116101","DOI":"10.1016\/j.ejca.2025.116101","article-title":"Letrozole to prevent breast cancer in postmenopausal women with BRCA1\/2\u00a0mutations (LIBER study)","volume":"231","author":"Pujol","year":"2025","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1016\/j.bulcan.2026.03.017_bib0895","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1001\/jamaoncol.2025.2203","article-title":"Defining lifetime risk thresholds for breast cancer surgical prevention","volume":"11","author":"Wei","year":"2025","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.bulcan.2026.03.017_bib0900","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41416-023-02503-8","article-title":"Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1\u00a0or BRCA2\u00a0pathogenic variant: an international analysis","volume":"130","author":"Metcalfe","year":"2024","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bulcan.2026.03.017_bib0905","series-title":"Contribution relative \u00e0 la mission de refondation de la sant\u00e9 publique. Rapport de l\u2019HCSP [Internet]","year":"2021"},{"key":"10.1016\/j.bulcan.2026.03.017_bib0910","unstructured":"A D, A D.\u00a0Minist\u00e8re de la Sant\u00e9, de la Famille, de l\u2019Autonomie et des Personnes handicap\u00e9es [Internet]. [cit\u00e9 6\u00a0nov 2025]. Dessiner la sant\u00e9 publique de demain. Disponible sur\u00a0: https:\/\/sante.gouv.fr\/ministere\/documentation-et-publications-officielles\/rapports\/sante\/article\/dessiner-la-sante-publique-de-demain."},{"key":"10.1016\/j.bulcan.2026.03.017_bib0915","series-title":"La place des offreurs de soins dans la pr\u00e9vention. Rapport de l\u2019HCSP [Internet]","year":"2018"},{"key":"10.1016\/j.bulcan.2026.03.017_bib0920","unstructured":"DGOS_Michel.C, DGOS_Michel.C.\u00a0Minist\u00e8re de la Sant\u00e9, de la Famille, de l\u2019Autonomie et des Personnes handicap\u00e9es [Internet]. [cit\u00e9 6\u00a0nov 2025]. Parcours de sant\u00e9, de soins et de vie. Disponible sur\u00a0: https:\/\/sante.gouv.fr\/systeme-de-sante\/parcours-des-patients-et-des-usagers\/article\/parcours-de-sante-de-soins-et-de-vie."},{"key":"10.1016\/j.bulcan.2026.03.017_bib0925","unstructured":"Minist\u00e8re de la Sant\u00e9 [Internet]. [cit\u00e9 6\u00a0nov 2025]. Tu as rendez-vous avec ta sant\u00e9. Disponible sur\u00a0: https:\/\/monbilanprevention.sante.gouv.fr."},{"issue":"1","key":"10.1016\/j.bulcan.2026.03.017_bib0930","first-page":"1","article-title":"INTERCEPTION\u00a0: construire la pr\u00e9vention des cancers de demain","volume":"9","author":"Veron","year":"2023","journal-title":"Innov Ther Oncol"},{"key":"10.1016\/j.bulcan.2026.03.017_bib0935","unstructured":"Health literacy development for the prevention and control of noncommunicable diseases: volume 4. Case studies from WHO National Health Literacy Demonstration Projects [Internet]. [cit\u00e9 6\u00a0nov 2025]. Disponible sur\u00a0: https:\/\/www.who.int\/publications\/i\/item\/9789240055391."},{"key":"10.1016\/j.bulcan.2026.03.017_bib0940","doi-asserted-by":"crossref","first-page":"1682320","DOI":"10.3389\/fpubh.2025.1682320","article-title":"Equity by design: integrating a Deprivation Index into digital platforms for breast cancer and chronic disease prevention-lessons from the ELISAH project","volume":"13","author":"Ussai","year":"2025","journal-title":"Front Public Health"},{"key":"10.1016\/j.bulcan.2026.03.017_bib0945","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s12913-025-12471-9","article-title":"Evaluation of a digital reporting and supporting tool in breast cancer prevention trials (KarmApp)","volume":"25","author":"Tapia","year":"2025","journal-title":"BMC Health Serv Res"},{"issue":"HS1","key":"10.1016\/j.bulcan.2026.03.017_bib0950","first-page":"191","article-title":"[Not available]","volume":"37","author":"Courie-Lemeur","year":"2025","journal-title":"Sante Publique"},{"issue":"1","key":"10.1016\/j.bulcan.2026.03.017_bib0955","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/08870446.2024.2395856","article-title":"Women's experiences of risk-stratified breast cancer screening in the MyPeBS trial: a qualitative comparative study across two European countries","volume":"41","author":"McWilliams","year":"2024","journal-title":"Psychol Health"},{"issue":"1","key":"10.1016\/j.bulcan.2026.03.017_bib0480","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1186\/s12885-025-13848-z","article-title":"Acceptability of risk-based breast cancer screening among professionals and healthcare providers from 6\u00a0countries contributing to the MyPeBS study","volume":"25","author":"Roux","year":"2025","journal-title":"BMC Cancer"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455126002791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455126002791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:29:58Z","timestamp":1784305798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455126002791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":96,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0007455126002791"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2026.03.017","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u00c9tat des lieux et innovations dans les strat\u00e9gies de pr\u00e9vention et d\u00e9pistage du cancer du sein","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2026.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}